Hutchison China Meditech LTD (HCM)

 

HCM Share PerformanceMore

52 week high2,896.50 09/12/15
52 week low1,612.50 28/04/16
52 week change -562.50 (-20.09%)
4 week volume384,394 06/11/16

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Exercise of Share Options

RNS Number: 5202Q Hutchison China Meditech Limited 30 November 2016 Exercise of Share Options by a Person Discharging Managerial Responsibilities London: Wednesday, November 30 , 2016: Hutchison China MediTech Limited ("Chi-Med") (AIM/Nasdaq: HCM) has received notification that Dr Weiguo Su, Executive Vice President and Chief Scientific Officer...

Total Voting Rights

RNS Number: 5198Q Hutchison China Meditech Limited 30 November 2016 Total Voting Rights London: Wednesday , November 30, 2016: For information purposes, Hutchison China MediTech Limited ("Chi-Med") (AIM/Nasdaq: HCM) hereby notifies the market that as at November 30, 2016, the issued share capital of Chi-Med consisted of 60,703,323 ordinary shares ...

Director Deals - Hutchison China Meditech Ltd (HCM)

Michael Howell, Non Executive Director, sold 10,000 shares in the company on the 21st November 2016 at a price of 1883.00...

Director's Share Dealing

RNS Number: 9176P Hutchison China Meditech Limited 23 November 2016 Director's Share Dealing London: Wednesday, November 23 , 2016: Hutchison China MediTech Limited ("Chi-Med") (AIM/Nasdaq: HCM) has received notification that Mr Michael Howell, Independent Non-executive Director, sold 10,000 ordinary shares of US$1.00 each in Chi-Med (the "Ordin...

Chi-Med to Present Data at the 17th WCLC

RNS Number: 9174P Hutchison China Meditech Limited 23 November 2016 Press Release Chi-Med to Present Data from Proof-of-Concept Clinical Trials for Fruquintinib and Epitinib at the 17 th World Conference on Lung Cancer ("WCLC") London: Wednesday, November 23, 2016: Hutchison China MediTech Limited ("Chi-Med") (AIM/Nasdaq: HCM) today annou...

Chi-Med to Present Data at the at the 17th WCLC

RNS Number: 9171P Hutchison China Meditech Limited 23 November 2016 Press Release Chi-Med to Present Data from Proof-of-Concept Clinical Trials for Fruquintinib and Epitinib at the 17 th World Conference on Lung Cancer ("WCLC") London: Wednesday, November 23, 2016: Hutchison China MediTech Limited ("Chi-Med") (AIM/Nasdaq: HCM) today annou...

Chi-Med to present clinical data at ACR/ARHP

Hutchison China MediTech says data from a recent phase I, first-in-human, dose escalating study of the safety, tolerability...

Chi-Med Presents Ph I Clinical Data for HMPL-523

RNS Number: 0875P Hutchison China Meditech Limited 14 November 2016 Press Release Chi-Med Presents Phase I Clinical Data for Selective S yk Inhibitor HMPL-523 at the 2016 ACR/ARHP Annual Meeting London: Monday , November 14 , 2016: Hutchison China MediTech Limited ("Chi-Med") (AIM/Nasdaq: HCM) today announces that data from a recent Phase I...

Equity Research (HCM)

Hutchison China MediTech Ltd.
03/08/2016
Chi-Med’s CEO, Christian Hogg, delivered a confident and convincing presentation at the recent interim analyst meeting. It was certainly refreshing to hear a CEO explain a drop in profits (and doing...
edison investment research
Hutchison China MediTech Ltd.
27/05/2016
Hutchison China MediTech (Chi-Med) (HCM) is an innovative biopharma company focused on the highly lucrative global oncology and immunology markets. HCM has built a substantial pipeline of potential...
edison investment research
Hutchison China MediTech Ltd.
05/03/2015
The next 12-18 months should be the defining period as Hutchison China MediTech transitions into a fully-fledged pharmaceutical business. Solid FY14 results confirm the continuing growth at China...

Latest discussion posts More

  • Re: Big buys?

    Today's RNS answers why there were number of big buys during the last few weeks. "Chi-Med Commercial Platform Joint Venture Receives US$59.5 Million Land Compensation ...
    31-Oct-2016
    sporty investor
  • Big buys?

    Number large trades and sp improving. Some good news on the way?
    25-Oct-2016
    sporty investor
  • Re: Any news?

    That's probably because there's not been any news released since the Interims ! Well, bar a NED selling ~10% of his holding I suppose Back in May Edison said we looked ...
    21-Oct-2016
    Boring Bernie

Users' HoldingsMore

Users who hold Hutchison China Meditech LTD also hold..
NATIONAL GRID22%
RDS 'B'20%
BP18%
GLAXOSMITHKLINE16%
VODAFONE GRP.13%

Codes & Symbols

ISINKYG4672N1016
SymbolsHCM, LSE:HCM, HCM.L, HCM:LN, LON:HCM, XLON:HCM